Browse Category

NYSE:LLY News 1 December 2025 - 11 December 2025

Eli Lilly (LLY) After Hours: How a $6 Billion Bet, Fresh Oncology Data and Fed Rate Cut Set the Stage for December 11, 2025

Eli Lilly (LLY) After Hours: How a $6 Billion Bet, Fresh Oncology Data and Fed Rate Cut Set the Stage for December 11, 2025

Eli Lilly and Company (NYSE: LLY) closed just under the psychologically important $1,000 mark on Wednesday, December 10, 2025, then ticked slightly higher in after‑hours trading as investors digested a wave of company‑specific news against a backdrop of a fresh
Eli Lilly Stock After Hours on December 9, 2025: 9‑Day Slide, $6B Alabama Bet and What to Watch Before the December 10 Open

Eli Lilly Stock After Hours on December 9, 2025: 9‑Day Slide, $6B Alabama Bet and What to Watch Before the December 10 Open

Eli Lilly and Company (NYSE: LLY) closed lower again on Tuesday, December 9, extending a rare nine‑session losing streak even as the drugmaker announced a multibillion‑dollar U.S. manufacturing expansion and positive cancer‑drug trial data. StockAnalysis+1 Heading into the U.S. stock
Eli Lilly Stock (LLY) on December 9, 2025: Price, Alabama Megaplant, Jaypirca Breakthrough and 2026–2030 Forecasts

Eli Lilly Stock (LLY) on December 9, 2025: Price, Alabama Megaplant, Jaypirca Breakthrough and 2026–2030 Forecasts

As of Tuesday, December 9, 2025, Eli Lilly (NYSE: LLY) sits at the center of nearly every conversation about obesity drugs, oncology breakthroughs and “next trillion‑dollar” stocks. The shares trade around $980 per share, down about 1.6% on the day but
1 2 3 4 6
Go toTop